🇺🇸 FDA
Pipeline program

PTC299

PTC299-ONC-004-AST

Phase 1 small_molecule terminated

Quick answer

PTC299 for Advanced Cancer is a Phase 1 program (small_molecule) at PTC THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
PTC THERAPEUTICS, INC.
Indication
Advanced Cancer
Phase
Phase 1
Modality
small_molecule
Status
terminated

Clinical trials